Michigan
CNS clinical trials in Michigan
100 CNS studies are recruiting participants at sites in 38 cities across Michigan as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Michigan city with a recruiting study
By research area: Depression (27), Parkinson's Disease (27), Multiple Sclerosis (15), Epilepsy (12), Migraine (11), ADHD (4), Schizophrenia (3), Bipolar Disorder (1).
Ann Arbor (47), Farmington Hills (19), Detroit (15), Grand Rapids (11), Bloomfield Hills (4), Rochester Hills (4), East Lansing (3), Farmington (3), Novi (3), Owosso (2), Southfield (2), Troy (2), Alma (1), Alpena (1), Bloomfield Township (1), Brownstown (1), Clinton Township (1), Dearborn (1), Flint (1), Gladwin (1), Jackson (1), Kalamazoo (1), Lansing (1), Livonia (1), Manistique (1), Marquette (1), Memphis (1), Midland (1), Mount Pleasant (1), Pokagon (1), Pontiac (1), Reed City (1), Royal Oak (1), Saginaw (1), Tawas City (1), Traverse City (1), West Bloomfield (1), Wyandotte (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Michigan
Basic details from each study's public record (the 12 most recently updated of 100). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
- No phase
- Ages 12 to 22
- All sexes
- Sponsor
- Michigan State University
- Recruiting in
- Grand Rapids
- Registry record
- NCT06232304 · updated
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Recruiting in
- Ann Arbor · Novi
- Registry record
- NCT07002034 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Michigan on ClinicalTrials.gov.
Parkinson's disease: recently updated in Michigan
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Ann Arbor
- Registry record
- NCT06989112 · updated
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Grand Rapids
- Registry record
- NCT06469944 · updated
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Phase 1/2
- Ages 45 and older
- All sexes
- Sponsor
- Prabesh Kanel
- Recruiting in
- Ann Arbor
- Registry record
- NCT07154511 · updated
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
- Phase 2
- Ages 40 to 85
- All sexes
- Sponsor
- H. Lundbeck A/S
- Recruiting in
- Farmington
- Registry record
- NCT07514858 · updated
SAD Study in Patients With Parkinson's Disease and Motor Fluctuations
- Phase 1
- Ages 40 to 80
- All sexes
- Sponsor
- Serina Therapeutics
- Recruiting in
- Farmington Hills
- Registry record
- NCT07422675 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Grand Rapids
- Registry record
- NCT06841354 · updated
Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease
- Observational
- Ages 50 to 85
- All sexes
- Sponsor
- CND Life Sciences
- Recruiting in
- Farmington Hills
- Registry record
- NCT07428447 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Michigan on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in Michigan
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- Rochester Hills
- Registry record
- NCT07299019 · updated
A Study of AZD0120 in Autoimmune Diseases
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- AstraZeneca
- Recruiting in
- Ann Arbor
- Registry record
- NCT07295847 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Michigan on ClinicalTrials.gov.
Migraine: recently updated in Michigan
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Recruiting in
- Ann Arbor · Farmington Hills
- Registry record
- NCT07616128 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Michigan on ClinicalTrials.gov.
Ask about studies in Michigan
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections